{"id":19694,"date":"2021-04-28T09:23:10","date_gmt":"2021-04-28T09:23:10","guid":{"rendered":"https:\/\/neuraxpharm.com\/it\/?p=19694"},"modified":"2022-12-13T09:06:59","modified_gmt":"2022-12-13T09:06:59","slug":"8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","status":"publish","type":"post","link":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","title":{"rendered":"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta"},"content":{"rendered":"

Epilepsie je onemocn\u011bn\u00ed centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu, kter\u00e9 postihuje v\u00edce ne\u017e 50 milion\u016f lid\u00ed na cel\u00e9m sv\u011bt\u011b, zp\u016fsobuje fyzick\u00e9 utrpen\u00ed, emo\u010dn\u00ed stres a ohro\u017euje nad\u011bje a sny.<\/p>\n

Nediskriminuje, postihuje v\u0161echny rasy, pohlav\u00ed a etnika, a p\u0159esto\u017ee je roz\u0161\u00ed\u0159en\u011bj\u0161\u00ed u d\u011bt\u00ed a lid\u00ed star\u0161\u00edch 65 let, m\u016f\u017ee se vyskytnout v jak\u00e9mkoli v\u011bku a m\u016f\u017ee z\u016fstat celo\u017eivotn\u00edm onemocn\u011bn\u00edm.<\/p>\n

Je zde pomoc \u2013 antiepileptika (AED), kter\u00e1 p\u0159edepisuj\u00ed l\u00e9ka\u0159i, mohou u v\u011bt\u0161iny lid\u00ed z\u00e1chvaty zastavit nebo zm\u00edrnit. Je zde nad\u011bje – v\u00fdzkum dek\u00f3duje p\u016fvod nemoci a mozkov\u00e9 dr\u00e1hy, aby tak podn\u00edtil v\u00fdvoj l\u00e9k\u016f a zlep\u0161en\u00ed l\u00e9\u010debn\u00fdch mo\u017enost\u00ed.<\/p>\n

Co v\u00edte o epilepsii?<\/h2>\n

V\u011bdeck\u00fd v\u00fdzkum n\u00e1m pomohl v\u00edce porozum\u011bt komplexn\u00ed fyziologii mozku, osv\u011btlit n\u011bkter\u00e9 mechanismy souvisej\u00edc\u00ed s epilepsi\u00ed a lokalizovat ohnisko z\u00e1chvat\u016f v mozku. Objevy tak\u00e9 uk\u00e1zaly, \u017ee epilepsie je r\u016fznorodou skupinou vz\u00e1cn\u00fdch onemocn\u011bn\u00ed, kter\u00e1 sd\u00edlej\u00ed predispozici k z\u00e1chvat\u016fm.<\/p>\n

Studie v genetice, metabolick\u00fdch zm\u011bn\u00e1ch, abnormalit\u00e1ch mozkov\u00e9 struktury, imunitn\u00edm syst\u00e9mu a infek\u010dn\u00edch nemocech identifikuj\u00ed potenci\u00e1ln\u00ed spou\u0161t\u011b\u010de z\u00e1chvat\u016f a zp\u016fsoby, jak m\u00edrnit nebo neutralizovat jejich \u00fa\u010dinky.<\/p>\n

\u00daloha gen\u016f je jednozna\u010dn\u011b v\u00fdznamn\u00e1 \u2013 v posledn\u00edch t\u0159ech letech bylo nov\u011b spojeno s epilepsi\u00ed na 50 gen\u016f1<\/sup>, ale jejich vztahy v kombinaci se zm\u011bnami ve struktu\u0159e mozku jsou slo\u017eit\u00e9 a obt\u00ed\u017en\u011b definovateln\u00e9.<\/p>\n

Dobrou zpr\u00e1vou v\u0161ak je, \u017ee shroma\u017e\u010fov\u00e1n\u00ed znalost\u00ed urychluje v\u00fdvoj c\u00edlen\u00fdch l\u00e9k\u016f a zvy\u0161uje p\u0159\u00edslib dostupnosti dal\u0161\u00edch mo\u017enost\u00ed l\u00e9\u010dby. Pro to, aby lid\u00e9 s epilepsi\u00ed mohli \u017e\u00edt bezpe\u010dn\u00fd, plnohodnotn\u00fd \u017eivot a aby nep\u0159eru\u0161ovali svou kari\u00e9ru, je nezbytn\u00e9 z\u00edskat tu spr\u00e1vnou l\u00e9\u010dbu a vyv\u00edjet nov\u00e1 l\u00e9\u010diva.<\/p>\n

Je zde hodn\u011b nad\u011bje. \u010cek\u00e1 n\u00e1s je\u0161t\u011b mnoho pr\u00e1ce.<\/p>\n

8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii<\/h2>\n
    \n
  1. Jedn\u00e1 se o poruchu centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu<\/strong><\/li>\n<\/ol>\n

    Epilepsie je neurologick\u00e9 onemocn\u011bn\u00ed, kter\u00e9 vyvol\u00e1v\u00e1 abnorm\u00e1ln\u00ed mozkovou aktivitu, nen\u00ed to ale<\/p>\n

    du\u0161evn\u00ed onemocn\u011bn\u00ed.<\/p>\n

    Statistiky jsou ohromuj\u00edc\u00ed: podle statistik WHO trp\u00ed epilepsi\u00ed v\u00edce ne\u017e \u0161est milion\u016f lid\u00ed z 850 milion\u016f obyvatel v 53 zem\u00edch Evropy,2<\/sup> p\u0159i\u010dem\u017e ka\u017ed\u00fd rok je diagnostikov\u00e1no 300 000 nov\u00fdch p\u0159\u00edpad\u016f. Evropsk\u00e9 sdru\u017een\u00ed Epilepsy Alliance Europe se domn\u00edv\u00e1, \u017ee a\u017e 40 procent pacient\u016f je spr\u00e1vn\u011b l\u00e9\u010deno3<\/sup>.<\/p>\n

    Uv\u00e1d\u00ed: \u201eDopad epilepsie daleko p\u0159esahuje z\u00e1chvaty, proto\u017ee mezery v l\u00e9\u010db\u011b jsou velk\u00e9, porozum\u011bn\u00ed ve\u0159ejnosti je omezen\u00e9 a soci\u00e1ln\u00ed stigma zp\u016fsobuje, \u017ee lid\u00e9 s epilepsi\u00ed \u017eij\u00ed v izolaci\u201c.<\/p>\n

      \n
    1. Ne u v\u0161ech z\u00e1chvat\u016f jsou p\u0159\u00edtomny k\u0159e\u010de; mohou se projevit pocity nete\u010dnosti nebo zmatenosti.<\/strong><\/li>\n<\/ol>\n

      Existuje v\u00edce ne\u017e 40 r\u016fzn\u00fdch typ\u016f z\u00e1chvat\u016f4<\/sup>, kter\u00e9 jsou v mozku vyvol\u00e1ny n\u00e1hl\u00fdmi, intenzivn\u00edmi v\u00fdboji elektrick\u00e9 aktivity a kter\u00e9 naru\u0161uj\u00ed sign\u00e1ly p\u0159en\u00e1\u0161ej\u00edc\u00ed pokyny do t\u011bla. Tyto zak\u00f3dovan\u00e9 zpr\u00e1vy mohou vyvolat \u0161irokou \u0161k\u00e1lu z\u00e1chvat\u016f, od k\u0159e\u010d\u00ed p\u0159es v\u00fdpadky a\u017e po ztr\u00e1tu pam\u011bti s r\u016fznou dobou trv\u00e1n\u00ed.<\/p>\n

      \u010casto p\u0159ich\u00e1zej\u00ed bez varov\u00e1n\u00ed nebo jen s nepatrn\u00fdm varov\u00e1n\u00edm a mohou se prezentovat jakkoliv, od m\u00edrn\u00fdch pocit\u016f nete\u010dnosti nebo zmatenosti, otup\u011blosti nebo poruch vid\u011bn\u00ed a\u017e po ztuhlost, trhav\u00e9 pohyby a ztr\u00e1tu v\u011bdom\u00ed.<\/p>\n

      Lid\u00e9 s epilepsi\u00ed mohou m\u00edt v\u00edce ne\u017e jeden typ z\u00e1chvatu. Epilepsie je u ka\u017ed\u00e9ho jin\u00e1 a z\u00e1kladn\u00ed p\u0159\u00ed\u010diny jsou slo\u017eit\u00e9 a obt\u00ed\u017en\u011b diagnostikovateln\u00e9.<\/p>\n

      Kdokoli s vysokou hore\u010dku, n\u00edzkou nebo vysokou hladinu cukru v krvi nebo traumatem mozku, stejn\u011b tak jako ti, co odvykaj\u00ed alkoholu nebo l\u00e9k\u016fm, mohou b\u00fdt n\u00e1chyln\u00ed k jednor\u00e1zov\u00e9mu z\u00e1chvatu, co\u017e ale nen\u00ed epilepsie. Ta je diagnostikov\u00e1na pouze tehdy, kdy\u017e se prod\u011blaj\u00ed dva nebo v\u00edce nevyprovokovan\u00fdch z\u00e1chvat\u016f a l\u00e9ka\u0159 p\u0159edpov\u00edd\u00e1, \u017ee jich bude pravd\u011bpodobn\u011b v\u00edce.<\/p>\n

      Z\u00edsk\u00e1n\u00ed diagn\u00f3zy je vstupn\u00ed branou ke zvl\u00e1dnut\u00ed dan\u00e9ho stavu a pro v\u011bt\u0161inu lid\u00ed k pokra\u010dov\u00e1n\u00ed ve sv\u00e9m \u017eivot\u011b.<\/p>\n

      Sv\u011btov\u00e1 zdravotnick\u00e1 organizace odhaduje, \u017ee a\u017e 70 % lid\u00ed s epilepsi\u00ed by mohlo \u017e\u00edt bez z\u00e1chvat\u016f, pokud by byli \u0159\u00e1dn\u011b diagnostikov\u00e1ni a l\u00e9\u010deni.<\/p>\n

        \n
      1. N\u011bkte\u0159\u00ed lid\u00e9 p\u0159i nich z\u016fstanou p\u0159i v\u011bdomi, zat\u00edmco jin\u00ed v\u011bdom\u00ed ztrat\u00ed.<\/strong><\/li>\n<\/ol>\n

        L\u00e9ka\u0159i rozd\u011bluj\u00ed z\u00e1chvaty do skupin, co\u017e jim usnad\u0148uje nasazen\u00ed vhodn\u00e9 l\u00e9\u010dby, ale pot\u00fdkaj\u00ed se s velk\u00fdm mno\u017estv\u00edm p\u0159\u00edznak\u016f. Oblast, ve kter\u00e9 doch\u00e1z\u00ed k intenzivn\u00ed elektrick\u00e9 aktivit\u011b, bude m\u00edt vliv na typ z\u00e1chvatu, kter\u00fd vyvol\u00e1.<\/p>\n

        Absence<\/em><\/strong> zp\u016fsobuje, \u017ee \u010dlov\u011bk je nep\u0159\u00edtomn\u00fd nebo nereaguje a m\u016f\u017ee se zd\u00e1t, \u017ee \u201esn\u00ed\u201c. Nemus\u00ed si ani v\u0161imnout, \u017ee k z\u00e1chvatu do\u0161lo.<\/p>\n

        Tonicko-klonick\u00e9<\/em><\/strong> z\u00e1chvaty <\/em><\/strong>zp\u016fsobuj\u00ed, \u017ee \u010dlov\u011bk ztuhne, upadne do bezv\u011bdom\u00ed, \u010dasto pad\u00e1 dozadu a p\u0159etrv\u00e1vaj\u00ed svalov\u00e9 k\u0159e\u010de, kter\u00e9 zp\u016fsobuj\u00ed trhav\u00e9 pohyby.<\/p>\n

        Dal\u0161\u00ed z\u00e1chvaty se mohou projevovat n\u00e1hl\u00fdm trhnut\u00edm, zat\u00edmco u jin\u00fdch lid\u00ed t\u011blo zcela ochabne. U n\u011bkter\u00fdch lid\u00ed se z\u00e1chvaty kombinuj\u00ed, zat\u00edmco u jin\u00fdch se vyskytuje jen jeden typ z\u00e1chvat\u016f. L\u00e9ka\u0159i si \u010dasto vy\u017e\u00e1daj\u00ed den\u00edk z\u00e1chvat\u016f, aby mohli sledovat jejich frekvenci a charakteristiky a up\u0159esnit tak diagn\u00f3zu a l\u00e9\u010debn\u00fd pl\u00e1n.<\/p>\n

          \n
        1. U 50 % pacient\u016f je p\u0159\u00ed\u010dina jejich epilepsie nezn\u00e1m\u00e1.<\/strong><\/li>\n<\/ol>\n

          Jasn\u00fdmi p\u0159\u00ed\u010dinami z\u00e1chvatu je trauma, po\u0161kozen\u00ed mozku p\u0159i narozen\u00ed, mrtvice nebo infekce, ale p\u0159ibli\u017en\u011b v polovin\u011b v\u0161ech p\u0159\u00edpad\u016f je obt\u00ed\u017en\u00e9 ur\u010dit zdroj. Mozek vys\u00edl\u00e1 ohromuj\u00edc\u00ed po\u010det a \u0159adu elektrick\u00fdch sign\u00e1l\u016f k ovl\u00e1d\u00e1n\u00ed t\u011bla a tyto komplexn\u00ed obvody je t\u011b\u017ek\u00e9 analyzovat.<\/p>\n

          MRI sken m\u016f\u017ee zdroj mozkov\u00e9 aktivity identifikovat a poskytnout v\u00edce vod\u00edtek k p\u016fvodu epilepsie, ale p\u0159\u00ed\u010dina zhruba 50 % p\u0159\u00edpad\u016f z\u016fst\u00e1v\u00e1 nezn\u00e1m\u00e1.<\/p>\n

            \n
          1. Epilepsie nen\u00ed du\u0161evn\u00ed onemocn\u011bn\u00ed.<\/strong><\/li>\n<\/ol>\n

            Naprost\u00e1 v\u011bt\u0161ina lid\u00ed s epilepsi\u00ed nem\u00e1 \u017e\u00e1dn\u00e9 kognitivn\u00ed ani psychick\u00e9 probl\u00e9my. V\u00fdzkum v\u0161ak odhaduje, \u017ee 35 procent lid\u00ed s epilepsi\u00ed trp\u00ed depres\u00ed kv\u016fli pot\u00ed\u017e\u00edm se zvl\u00e1d\u00e1n\u00edm z\u00e1chvat\u016f a dopadu na jejich osobn\u00ed a profesn\u00ed \u017eivot.<\/p>\n

            Tento stav m\u016f\u017ee vyvolat \u00fazkost a ve v\u00fdzkumn\u00e9 studii se do\u0161lo k z\u00e1v\u011bru, \u017ee u dosp\u011bl\u00fdch s aktivn\u00ed epilepsi\u00ed je t\u0159ikr\u00e1t vy\u0161\u0161\u00ed pravd\u011bpodobnost v\u00fdskytu deprese, ne\u017e je tomu u osob bez epilepsie5<\/sup>.<\/p>\n

            Dal\u0161\u00ed v\u00fdzkum uk\u00e1zal, \u017ee oblasti mozku, kter\u00e9 jsou zodpov\u011bdn\u00e9 za z\u00e1chvaty, mohou ovliv\u0148ovat n\u00e1ladu a \u017ee p\u0159etrv\u00e1vaj\u00edc\u00ed stigma kolem epilepsie a jej\u00ed negativn\u00ed dopad na pr\u00e1ci a vztahy m\u016f\u017ee v\u00e9st ke stresu a \u00fazkosti.<\/p>\n

              \n
            1. Fotosenzitivita p\u0159i expozici blikaj\u00edc\u00edmu nebo mihotav\u00e9mu sv\u011btlu m\u016f\u017ee vyvolat z\u00e1chvat u t\u0159\u00ed procent lid\u00ed s epilepsi\u00ed.<\/strong><\/li>\n<\/ol>\n

              Fotosenzitivn\u00ed epilepsii m\u016f\u017ee vyvolat blik\u00e1n\u00ed nebo mihot\u00e1n\u00ed sv\u011btel s frekvenc\u00ed 16 a\u017e 25kr\u00e1t za sekundu, i kdy\u017e u n\u011bkter\u00fdch lid\u00ed to m\u016f\u017ee b\u00fdt pouze 3kr\u00e1t za sekundu. Blikaj\u00edc\u00edmi obrazy a vzory m\u016f\u017ee b\u00fdt cokoliv, od cyklistick\u00fdch a v\u00e1no\u010dn\u00edch sv\u011btel a\u017e po televizn\u00ed obrazovky a stroboskopick\u00e1 sv\u011btla.<\/p>\n

              Je \u010dast\u011bj\u0161\u00ed u d\u011bt\u00ed ve v\u011bku 7 a\u017e 19 let, p\u0159i\u010dem\u017e \u017eeny maj\u00ed o n\u011bco vy\u0161\u0161\u00ed pravd\u011bpodobnost v\u00fdskytu fotosenzitivn\u00ed epilepsie ne\u017e mu\u017ei.<\/p>\n

                \n
              1. Mrtvice a Alzheimerova choroba jsou hlavn\u00edmi faktory, kter\u00e9 spou\u0161t\u00ed epilepsii u senior\u016f. <\/strong><\/li>\n<\/ol>\n

                Lid\u00e9 s Alzheimerovou chorobu maj\u00ed vy\u0161\u0161\u00ed riziko epilepsie, kter\u00e1 se u v\u011bt\u0161iny z nich prezentuje kr\u00e1tkou periodou \u010d\u00e1ste\u010dn\u00e9 nebo \u00fapln\u00e9 ztr\u00e1ty pam\u011bti nebo apati\u00ed sp\u00ed\u0161e, ne\u017e fyzicky zjevn\u00fdmi z\u00e1chvaty. N\u00e1stup m\u016f\u017ee b\u00fdt zp\u016fsoben zm\u011bnami ve struktu\u0159e mozku zp\u016fsoben\u00fdmi bun\u011b\u010dnou smrt\u00ed a zmen\u0161ov\u00e1n\u00edm mozku st\u00e1rnut\u00edm.<\/p>\n

                O\u010dek\u00e1v\u00e1 se, \u017ee po\u010det lid\u00ed star\u0161\u00edch 65 let na cel\u00e9m sv\u011bt\u011b vzroste do roku 2050 z dne\u0161n\u00edch p\u0159ibli\u017en\u011b dev\u00edti procent na 17 procent (1,6 miliardy).<\/p>\n

                  \n
                1. Antiepileptika (AED) kontroluj\u00ed stav u 70 procent lid\u00ed sn\u00ed\u017een\u00edm elektrick\u00e9 aktivity v neuronech mozku.<\/strong><\/li>\n<\/ol>\n

                  L\u00e9ka\u0159i maj\u00ed k dispozici v\u00edce ne\u017e 20 AED, kter\u00e1 mohou p\u0159edepsat pro kontrolu epilepsie. AED stav nel\u00e9\u010d\u00ed, ale kontroluj\u00ed hladiny chemick\u00fdch l\u00e1tek v mozku, kter\u00e9 ovliv\u0148uj\u00ed elektrickou aktivitu a potenci\u00e1ln\u00ed z\u00e1chvaty.<\/p>\n

                  Prvn\u00ed nasazen\u00fd l\u00e9k zastav\u00ed pom\u011brn\u011b rychle z\u00e1chvaty u zhruba 60 % lid\u00ed s epilepsi\u00ed, ale n\u011bkte\u0159\u00ed lid\u00e9 reaguj\u00ed a\u017e za del\u0161\u00ed dobu a mohou pot\u0159ebovat dal\u0161\u00ed medikaci6<\/sup>.<\/p>\n

                  Epilepsie a spole\u010dnost<\/p>\n

                  Osobn\u00ed a spole\u010densk\u00e1 z\u00e1t\u011b\u017e je obrovsk\u00e1, ale mozek je nejm\u00e9n\u011b prozkouman\u00fdm a pochopen\u00fdm prvkem biologie \u010dlov\u011bka, co\u017e znamen\u00e1, \u017ee pokrok je t\u011b\u017ece vybojovan\u00fd a nen\u00ed tak rychl\u00fd jako v jin\u00fdch oblastech medic\u00edny. Byla to dlouh\u00e1 cesta od \u0159eck\u00e9ho filozofa Hippokrata (460-377 p\u0159. n. l.), kter\u00fd prosazoval teorii spojitosti epilepsie a mozku k modern\u00ed technologii vyu\u017e\u00edvaj\u00edc\u00ed neurologick\u00e9 zobrazov\u00e1n\u00ed k nahl\u00e9dnut\u00ed do funkce neuron\u016f.<\/p>\n

                  Epilepsie je po Alzheimerov\u011b chorob\u011b a mozkov\u00e9 p\u0159\u00edhod\u011b t\u0159et\u00edm nej\u010dast\u011bj\u0161\u00edm neurologick\u00fdm onemocn\u011bn\u00edm v Evrop\u011b a z\u016fst\u00e1v\u00e1 stavem, kter\u00fd p\u0159in\u00e1\u0161\u00ed nejistotu a naru\u0161en\u00ed \u017eivota lid\u00ed a z\u00e1rove\u0148 p\u0159edstavuje v\u00fdznamnou z\u00e1t\u011b\u017e pro syst\u00e9my zdravotn\u00ed p\u00e9\u010de a n\u00e1rodn\u00ed ekonomiky.<\/p>\n

                   <\/p>\n

                  Odkazy:<\/h3>\n

                  (1) Hebbar M, Mefford HC. Recent advances in epilepsy genomics and genetic testing.\u00a0F1000Res<\/em>. 2020; 9: F1000 Faculty Rev-185. Published 2020 Mar 12. doi: 10.12688\/f1000research.21366.1<\/p>\n

                  (2) World Health Organization. Epilepsy. Accessed January 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy<\/a><\/p>\n

                  (3) Epilepsy Alliance Europe. Background. Accessed January 2021. https:\/\/www.epilepsyallianceeurope.org\/about\/background\/<\/a><\/p>\n

                  (4) Epilepsy Society. Epilepsy facts and myths. Accessed January 2021. https:\/\/epilepsysociety.org.uk\/facts-and-statistics<\/a><\/p>\n

                  (5) Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 HealthStyles Survey. Epilepsia. 2006; 47(11): 1915-1921. doi:10.1111\/j.1528-1167.2006.00612.x<\/p>\n

                  (6) Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P T. 2010;35(7):392-415.<\/p>\n","protected":false},"excerpt":{"rendered":"

                  Epilepsie je onemocn\u011bn\u00ed centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu, kter\u00e9 postihuje v\u00edce ne\u017e 50 milion\u016f lid\u00ed na cel\u00e9m sv\u011bt\u011b, zp\u016fsobuje fyzick\u00e9 utrpen\u00ed, emo\u010dn\u00ed stres a ohro\u017euje nad\u011bje a sny.<\/p>\n","protected":false},"author":11,"featured_media":6836,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-19694","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-epilepsie"],"yoast_head":"\n8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta - Neuraxpharm CZ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta\" \/>\n<meta property=\"og:description\" content=\"Epilepsie je onemocn\u011bn\u00ed centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu, kter\u00e9 postihuje v\u00edce ne\u017e 50 milion\u016f lid\u00ed na cel\u00e9m sv\u011bt\u011b, zp\u016fsobuje fyzick\u00e9 utrpen\u00ed, emo\u010dn\u00ed stres a ohro\u017euje nad\u011bje a sny.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm CZ\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T09:23:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-13T09:06:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1916\" \/>\n\t<meta property=\"og:image:height\" content=\"824\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Danny Buckland\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napsal(a)\" \/>\n\t<meta name=\"twitter:data1\" content=\"Danny Buckland\" \/>\n\t<meta name=\"twitter:label2\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta\",\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta\",\"name\":\"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta - Neuraxpharm CZ\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg\",\"datePublished\":\"2021-04-28T09:23:10+00:00\",\"dateModified\":\"2022-12-13T09:06:59+00:00\",\"author\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/5e98de21df7792c42f65519659dc4ed1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage\",\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg\",\"contentUrl\":\"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg\",\"width\":1916,\"height\":824},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuraxpharm.com\/cz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/\",\"name\":\"Neuraxpharm CZ\",\"description\":\"Evropsk\u00fd l\u00eddr v oblasti produkt\u016f CNS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/cz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/5e98de21df7792c42f65519659dc4ed1\",\"name\":\"Danny Buckland\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1a728648f44c72edbe4c3d0925c08b1ec3087349d29145fbceffb6e90fca7904?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1a728648f44c72edbe4c3d0925c08b1ec3087349d29145fbceffb6e90fca7904?s=96&d=mm&r=g\",\"caption\":\"Danny Buckland\"},\"description\":\"Danny Buckland is an award-winning journalist who writes about health for newspapers, magazines and online outlets across Europe. His work ranges across all healthcare topics with a strong accent on innovation in technology, drug development and system redesign to meet growing challenges. He has produced White Papers and thought leadership articles for a range of clients and charities, moderates panel discussions and generates engaging content.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/danny-buckland-8252a16\/\"],\"url\":\"https:\/\/www.neuraxpharm.com\/cz\/blog\/author\/dbuckland\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta - Neuraxpharm CZ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","og_locale":"cs_CZ","og_type":"article","og_title":"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta","og_description":"Epilepsie je onemocn\u011bn\u00ed centr\u00e1ln\u00edho nervov\u00e9ho syst\u00e9mu, kter\u00e9 postihuje v\u00edce ne\u017e 50 milion\u016f lid\u00ed na cel\u00e9m sv\u011bt\u011b, zp\u016fsobuje fyzick\u00e9 utrpen\u00ed, emo\u010dn\u00ed stres a ohro\u017euje nad\u011bje a sny.","og_url":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","og_site_name":"Neuraxpharm CZ","article_published_time":"2021-04-28T09:23:10+00:00","article_modified_time":"2022-12-13T09:06:59+00:00","og_image":[{"width":1916,"height":824,"url":"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg","type":"image\/jpeg"}],"author":"Danny Buckland","twitter_card":"summary_large_image","twitter_misc":{"Napsal(a)":"Danny Buckland","Odhadovan\u00e1 doba \u010dten\u00ed":"7 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","url":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta","name":"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta - Neuraxpharm CZ","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg","datePublished":"2021-04-28T09:23:10+00:00","dateModified":"2022-12-13T09:06:59+00:00","author":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/5e98de21df7792c42f65519659dc4ed1"},"breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta"]}]},{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#primaryimage","url":"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg","contentUrl":"https:\/\/www.neuraxpharm.com\/cz\/wp-content\/uploads\/sites\/27\/2021\/03\/epilepsy-facts.jpg","width":1916,"height":824},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/cz\/blog\/8-veci-ktere-byste-meli-vedet-o-epilepsii-zakladni-fakta#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/cz\/"},{"@type":"ListItem","position":2,"name":"8 v\u011bc\u00ed, kter\u00e9 byste m\u011bli v\u011bd\u011bt o epilepsii: Z\u00e1kladn\u00ed fakta"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/cz\/#website","url":"https:\/\/www.neuraxpharm.com\/cz\/","name":"Neuraxpharm CZ","description":"Evropsk\u00fd l\u00eddr v oblasti produkt\u016f CNS","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/cz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"},{"@type":"Person","@id":"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/5e98de21df7792c42f65519659dc4ed1","name":"Danny Buckland","image":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/www.neuraxpharm.com\/cz\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1a728648f44c72edbe4c3d0925c08b1ec3087349d29145fbceffb6e90fca7904?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1a728648f44c72edbe4c3d0925c08b1ec3087349d29145fbceffb6e90fca7904?s=96&d=mm&r=g","caption":"Danny Buckland"},"description":"Danny Buckland is an award-winning journalist who writes about health for newspapers, magazines and online outlets across Europe. His work ranges across all healthcare topics with a strong accent on innovation in technology, drug development and system redesign to meet growing challenges. He has produced White Papers and thought leadership articles for a range of clients and charities, moderates panel discussions and generates engaging content.","sameAs":["https:\/\/www.linkedin.com\/in\/danny-buckland-8252a16\/"],"url":"https:\/\/www.neuraxpharm.com\/cz\/blog\/author\/dbuckland"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/posts\/19694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/comments?post=19694"}],"version-history":[{"count":11,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/posts\/19694\/revisions"}],"predecessor-version":[{"id":24798,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/posts\/19694\/revisions\/24798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/media\/6836"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/media?parent=19694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/categories?post=19694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/cz\/wp-json\/wp\/v2\/tags?post=19694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}